Search Results - "Beuvelet, Matthieu"
-
1
Disease Burden Associated with All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization with Nirsevimab Against RSV-Related Outcomes
Published in Infectious diseases and therapy (01-10-2024)“…Introduction Respiratory syncytial virus (RSV) leads to significant morbidity in newborn infants in the United Kingdom (UK). Nirsevimab, a long-acting…”
Get full text
Journal Article -
2
Modelling the potential clinical and economic impact of universal immunisation with nirsevimab versus standard of practice for protecting all neonates and infants in their first respiratory syncytial virus season in Spain
Published in BMC infectious diseases (06-09-2024)“…Respiratory syncytial virus (RSV) is associated with substantial morbidity among infants. This study modelled the potential public health and economic impact…”
Get full text
Journal Article -
3
Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model
Published in The Journal of infectious diseases (15-08-2022)“…Respiratory syncytial virus (RSV) is associated with substantial morbidity in the United States, especially among infants. Nirsevimab, an investigational…”
Get full text
Journal Article -
4
Response to Fullarton et al
Published in The Journal of infectious diseases (29-05-2023)Get full text
Journal Article -
5
Respiratory Syncytial Virus (RSV) Burden in Infants in the Kingdom of Saudi Arabia and the Impact of All-Infant RSV Protection: A Modeling Study
Published in Advances in therapy (01-04-2024)“…Introduction Respiratory syncytial virus (RSV) represents a considerable burden on the healthcare system and hospital resources. This study explored the impact…”
Get full text
Journal Article